|
|
|
| Welcoming over 9,000+ industry professionals, INTERPHEX is the leading global pharmaceutical and biotechnology event that fuses industry innovation with expert-led conference. It's where the newest ideas are shared, technology is unveiled, and the power of science though commercialization comes to life. No matter where you are in the pharmaceutical development lifecycle, INTERPHEX delivers relevant solutions to drive growth and fuel scalability for your business. Learn more |
|
|
|
|
|
| Progress In LC-MS-Based Metabolomics Techniques | Article | By Pegah R. Jalili, Ph.D., and Kevin Ray, Ph.D., MilliporeSigma | Get updated on recent advances in metabolome analysis by mass spectrometry with this introduction to the different approaches and technologies. |
|
|
| How To Select The Ideal HPAPI Manufacturing Partner | Article | By Karel Vervisch, Ph.D., Ajinomoto Bio-Pharma Services | To ensure the safety of personnel throughout the production of HPAPIs, manufacturers must effectively utilize containment and well-designed equipment. |
|
|
| Developing Effective Procedures | White Paper | By Jeff Hall & Lisa Hawkins, CAI | Effective procedure development starts with understanding the purpose and should integrate change management, risk management, and knowledge management to ensure a robust quality system. |
|
|
|
| Setting The Standard In Cell And Gene Therapy | White Paper | Sartorius | Here, we discuss the challenges and solutions for cell and gene therapies, focusing on performance, scalability, and regulatory compliance to accelerate commercialization and improve patient access. |
|
|
|
|
| Leveraging Tools To Create Optimized Solutions | Q&A | Adare Pharma Solutions | Review the key trends and challenges shaping the CDMO industry as well as the tools helping a leading CDMO meet the growing demand for pediatric formulations and taste-masking solutions. |
|
|
|
| Spray Drying For Improved Solubility | Q&A | Lonza | Gain expert insights into how to develop a spray-dried powder formulation and scale it from early feasibility studies to commercial manufacturing. |
|
|
|
|
|
|
|
| Placing Patients At The Center Of Drug Design | Q&A | Catalent | Experts discuss the best time to start thinking about patient-centricity, the steps developers can take to achieve patient-centric drug design, and how formulation and dosage forms can make a difference. |
|
|
|
|
By Ankitkumar C. Patel, senior QA/QC specialist | The building blocks of such successful packaging relationships include a thoughtful approach to quality service agreements, a culture of transparency, and more. |
|
|
|
|
|
|
|
|
|
|
|
|
Connect With Pharmaceutical Online: |
|
|
|